Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Cell-free fat extract may boost IVF success in older women with past failures.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Melatonin helps reduce aging signs in human eyelid skin.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Platelet-rich plasma can help thicken the endometrium and improve pregnancy rates.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

ABO/Rh blood groups are not a risk factor for PCOS.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.